BIOXYTRAN, INC Operating Income Loss

• BIOXYTRAN, INC showed an increase of +41.5% in Operating Income Loss from 2023 to 2024.
• This data is from BIOXYTRAN, INC's annual report (Form 10-K), filed with the SEC on April 3, 2025.
• XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2010 to 2024), BIOXYTRAN, INC's Operating Income Loss has declined by 575.6%.
• Historical annual values: Fiscal year 2024: -$2.22 million | Fiscal year 2023: -$3.80 million | Fiscal year 2022: -$2.13 million | Fiscal year 2021: -$4.21 million | Fiscal year 2020: -$1.27 million | Fiscal year 2019: -$1.63 million | Fiscal year 2018: -$215.1 thousand | Fiscal year 2017: -$310.6 thousand | Fiscal year 2016: -$671.3 thousand | Fiscal year 2015: -$2.09 million | Fiscal year 2014: -$1.28 million | Fiscal year 2013: -$1.97 million | Fiscal year 2012: -$2.29 million | Fiscal year 2011: -$4.43 million | Fiscal year 2010: -$329.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026